Uncomplicated Urinary Tract Infections in Women

Obstetrics and Gynecology Clinics of North America

Volumn 35, Issue 2, 2008, Pages 235-248

  Foster Sr , Raymond T ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CIPROFLOXACIN; COTRIMOXAZOLE; ENOXACIN; ESTROGEN; FLEROXACIN; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFANILAMIDE; SULFONAMIDE; TRIMETHOPRIM; VACCINE;

AGRANULOCYTOSIS; ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; CLINICAL FEATURE; CLINICAL TRIAL; CRANBERRY; CYANOSIS; CYSTITIS; DRUG COST; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; INFECTION RISK; KLEBSIELLA; LABORATORY TEST; LACTOBACILLUS; LOW DRUG DOSE; MEDICARE; META ANALYSIS; MILK; NONHUMAN; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEUS; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; REVIEW; RISK FACTOR; RISK REDUCTION; SEXUAL INTERCOURSE; SINGLE DRUG DOSE; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; RECURRENCE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 43649094777     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2008.03.003     Document Type: Review

References (53)

1. Foxman B., and Frerichs R.R. Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse. Am J Public Health 75 (1985) 1308-1313
2. Foxman B., Barlow R., D'Arcy H., et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10 (2000) 509-515
3. Zielske J.V., Lohr K.N., Brook R.H., et al. Conceptualization and measurement of physiologic health for adults. Urinary tract infection. [report] (1981), The Rand Corporation
4. Hooton T.M., Scholes D., Hughes J.P., et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335 (1996) 468-474
5. Curns A.T., Holman R.C., Sejvar J.J., et al. Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med 165 (2005) 2514-2520
6. Litwin M.S., Saigal C.S., and Beerbohm E.M. The burden of urologic diseases in America. J Urol 173 (2005) 1605-1606
7. Griebling T.L. Urologic Diseases in America Project: trends in resource use for urinary tract infections in men. J Urol 173 (2005) 1288-1294
8. Nickel JC. Management of urinary tract infections: historical perspective and current strategies: part 1-before antibiotics. J Urol 173 (2005) 21-26
9. Helmholz H.F., and Osterberg A.E. The effect of pH of the urine on concentration of free and conjugated sulfanilamide necessary for bactericidal action. Proceedings of the Staff Meetings Mayo Clinic 12 (1937) 661-664
10. Podolsky M. Cures out of chaos (1997), Harwood Academic Publishers, Newark (NJ)
11. Crenshaw J.L., and Cook E.N. Limitations, dangers, and failures of sulfanilamide in the treatment of urinary tract infections. J Urol 41 (1939) 64-68
12. Hu K.K., Boyko E.J., Scholes D., et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 164 (2004) 989-993
13. Wilson J.D., Lee R.A., Balen A.H., et al. Bacterial vaginal flora in relation to changing oestrogen levels. Int J STD AIDS 18 (2007) 308-311
14. Raz R., and Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329 (1993) 753-756
15. Stamm W.E., and Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 28 (1999) 723-725
16. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182 (2000) 1177-1182
17. Anger J.T., Litwin M.S., Wang Q., et al. Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol 109 (2007) 707-714
18. Athanasiou S., Anstaklis A., Betsi G.I., et al. Clinical and urodynamic parameters associated with history of urinary tract infections in women. Acta Obstet Gynecol Scand 86 (2007) 1130-1135
19. Kontiokari T., Laitinen J., Jarvi L., et al. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr 77 (2003) 600-604
20. Medina-Bombardo D., Segui-Diaz M., Roca-Fusalba C., et al. What is the predictive value of urinary symptoms for diagnosing urinary tract infection in women?. [erratum appears in Fam Pract 2003;20(5):619-21]. Fam Pract 20 (2003) 103-107
21. Bent S., Nallamothu B.K., Simel D.L., et al. Does this woman have an acute uncomplicated urinary tract infection?. [see comment]. JAMA 287 (2002) 2701-2710
22. Savaris R.F., Teixeira L.M., and Torres T.G. Bladder tenderness as a physical sign for diagnosing cystitis in women. Int J Gynaecol Obstet 93 (2006) 256-257
23. Wigton R.S., Hoellerich V.L., Ornato J.P., et al. Use of clinical findings in the diagnosis of urinary tract infection in women. Arch Intern Med 145 (1985) 2222-2227
24. Wong E.S., Fennell C.L., and Stamm W.E. Urinary tract infection among women attending a clinic for sexually transmitted diseases. Sex Transm Dis 11 (1984) 18-23
25. Deville W.L., Yzermans J.C., van Duijn N.P., et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol 4 (2004) 1-14
26. Gorelick M.H., and Shaw K.N. Screening tests for urinary tract infection in children: a meta-analysis. Pediatrics 104 (1999) e54
27. Hurlbut III T.A., and Littenberg B. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol 96 (1991) 582-588
28. Richards D., Toop L., Chambers S., et al. Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial. BMJ 331 (2005) 143-145
29. Hooton T.M. Practice guidelines for urinary tract infection in the era of managed care. Int J Antimicrob Agents 11 (1999) 241-245
30. De Francesco M.A., Ravizzola G., Peroni L., et al. Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit 13 (2007) BR136-BR144
31. Falagas M.E., Polemis M., Alexiou V.G., et al. Antimicrobial resistance of Escherichia coli urinary isolates from primary care patients in Greece. Med Sci Monit 14 (2008) CR75-CR79
32. Gupta K., Scholes D., and Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281 (1999) 736-738
33. Gupta K., Hooton T.M., Wobbe C.L., et al. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 11 (1999) 305-308
34. Zhanel G.G., Hisanaga T.L., Laing N.M., et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 26 (2005) 380-388
35. Goettsch W.G., Janknegt R., and Herings R.M. Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol 58 (2004) 184-189
36. Gupta K., Hooton T.M., Roberts P.L., et al. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 167 (2007) 2207-2212
37. Vogel T., Verreault R., Gourdeau M., et al. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 170 (2004) 469-473
38. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29 (1999) 745-758
39. Naber K.G. Treatment options for acute uncomplicated cystitis in adults. J Antimicrob Chemother 46 Suppl 1 (2000) 23-27
40. Stamey T.A., Condy M., and Mihara G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora. N Engl J Med 296 (1977) 780-783
41. Martinez F.C., Kindrachuk R.W., Thomas E., et al. Effect of prophylactic, low dose cephalexin on fecal and vaginal bacteria. J Urol 133 (1985) 994-996
42. Stamm W.E., Counts G.W., McKevitt M., et al. Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control. Rev Infect Dis 4 (1982) 450-455
43. Wong E.S., McKevitt M., Running K., et al. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med 102 (1985) 302-307
44. Melekos M.D., Asbach H.W., Gerharz E., et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 157 (1997) 935-939
45. Pfau A., Sacks T., and Engelstein D. Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis. J Urol 129 (1983) 1153-1157
46. Vosti K.L. Recurrent urinary tract infections. Prevention by prophylactic antibiotics after sexual intercourse. JAMA 231 (1975) 934-940
47. Gupta K., Hooton T.M., Roberts P.L., et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 135 (2001) 9-16
48. Schaeffer A.J., and Stuppy B.A. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 161 (1999) 207-211
49. Bailey D.T., Dalton C., Joseph Daugherty F., et al. Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study. Phytomedicine 14 (2007) 237-241
50. Di Martino P., Agniel R., David K., et al. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol 24 (2006) 21-27
51. Santillo V.M., and Lowe F.C. Cranberry juice for the prevention and treatment of urinary tract infections. Drugs Today (Barc) 43 (2007) 47-54
52. Jepson R., and Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 1 (2008) CD001321
53. Uehling D.T., Hopkins W.J., Elkahwaji J.E., et al. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 170 (2003) 867-869